BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17940477)

  • 1. Risk of venous thromboembolism in lung cancer.
    Tesselaar ME; Osanto S
    Curr Opin Pulm Med; 2007 Sep; 13(5):362-7. PubMed ID: 17940477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced thrombosis.
    Haddad TC; Greeno EW
    Thromb Res; 2006; 118(5):555-68. PubMed ID: 16388837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Occult cancer and pulmonary embolism].
    Debourdeau P; Farge-Bancel D
    Rev Prat; 2007 Apr; 57(7):737-42. PubMed ID: 17626318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
    Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
    Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.
    Wun T; White RH
    Cancer Invest; 2009; 27 Suppl 1():63-74. PubMed ID: 19291526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism in ovarian cancer.
    Rodriguez AO; Wun T; Chew H; Zhou H; Harvey D; White RH
    Gynecol Oncol; 2007 Jun; 105(3):784-90. PubMed ID: 17408726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in patients receiving multimodality therapy for thoracic malignancies.
    Patel A; Anraku M; Darling GE; Shepherd FA; Pierre AF; Waddell TK; Keshavjee S; de Perrot M
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):843-8. PubMed ID: 19660355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of pneumonectomy after induction therapy for locally advanced non-small cell lung cancer.
    d'Amato TA; Ashrafi AS; Schuchert MJ; Alshehab DS; Seely AJ; Shamji FM; Maziak DE; Sundaresan SR; Ferson PF; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2009 Oct; 88(4):1079-85. PubMed ID: 19766784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries.
    Al Sayegh F; Almahmeed W; Al Humood S; Marashi M; Bahr A; Al Mahdi H; Bakir S; Al Farhan M
    Clin Appl Thromb Hemost; 2009; 15(3):289-96. PubMed ID: 18400764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying cancer patients at risk for venous thromboembolism.
    Sousou T; Khorana A
    Hamostaseologie; 2009 Jan; 29(1):121-4. PubMed ID: 19151861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Place of cancer among the risk factors in venous thromboembolism].
    Descourt R; Righini M; Carrier M; Le Gal G
    Pathol Biol (Paris); 2008 Jun; 56(4):178-83. PubMed ID: 18325691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Di Micco P; Iannuzzo M; Lecumberri R; Guijarro R; Madridano O; Monreal M;
    Thromb Haemost; 2008 Nov; 100(5):905-11. PubMed ID: 18989537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology.
    Winter PC
    Hematol Oncol; 2006 Sep; 24(3):126-33. PubMed ID: 16783843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
    Streiff MB
    J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis.
    Goldin-Lang P; Tran QV; Fichtner I; Eisenreich A; Antoniak S; Schulze K; Coupland SE; Poller W; Schultheiss HP; Rauch U
    Oncol Rep; 2008 Jul; 20(1):123-8. PubMed ID: 18575726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulopathic complications in breast cancer.
    Caine GJ; Stonelake PS; Rea D; Lip GY
    Cancer; 2003 Oct; 98(8):1578-86. PubMed ID: 14534872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer.
    Dentali F; Malato A; Ageno W; Imperatori A; Cajozzo M; Rotolo N; Douketis J; Siragusa S; Crowther M
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):705-6. PubMed ID: 18329505
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting recurrences or major bleeding in women with cancer and venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Ruiz-Gamietea A; Luque JM; Samperiz AL; Garcia-Bragado F; Todoli JA; Monreal M;
    Thromb Res; 2009; 123 Suppl 2():S10-5. PubMed ID: 19217463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.